82
Participants
Start Date
January 31, 2013
Primary Completion Date
May 31, 2014
Study Completion Date
May 25, 2014
Base level of remifentanil effect side concentration: 2ng/ml
constant remifentanil level of 2ng/ml administered using Target Control Infusion pumps.
Base level of remifentanil effect side concentration: 4ng/ml
constant remifentanil level of 4ng/ml administered using Target Control Infusion pumps.
chronic beta-blocker treatment
Patients from the chronic beta-blocker treatment group will not be randomized, and will all be allocated to the high opioid level group.
Rambam Health Care Campus, Haifa
Lead Sponsor
Medasense Biometrics Ltd
OTHER